ACTRN12612000345886招募中未知
Circulating Tumour DNA as a Sensitive and Specific Marker of Response to Therapy and of Occult Disease in Colorectal Cancer
udwig Institute for Cancer Research0 个研究点目标入组 100 人开始时间: 2012年3月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Patients with histologically confirmed primary colorectal cancer
- •2. Patients with resected primary tumours or planned for curative primary tumour resection.
- •3. Patients with resectable liver metastases following workup including CT scans of chest, abdomen and pelvis (or MRI if unable to undertake CT scan) and whole body PET scan.
- •4. Patients fit for surgery
- •5. Patients fit for combination chemotherapy (5-FU and oxaliplatin)
- •6. Patients willing to provide written informed consent
排除标准
- •1. History of another primary cancer within the last 5 years, with the exception of non-melanomatous skin cancer and carcinoma in situ of the cervix.
- •2. Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the protocol
- •3. Patients that are not accessible for follow-up
研究者
相似试验
尚未招募
不适用
Circulating Tumour DNA as a Marker of Complete Pathological Response and Long Term Outcome for Locally Advanced Rectal Cancer Treated with Pre-operative ChemoradiotherapyACTRN12612000327886udwig Institute for Cancer Research320
进行中（未招募）
1 期
CIRCULATE - A TRIAL TO IMPROVE CARE OF PATIENTS AFTER COLON TUMOR SURGERY, BASED ON AN INNOVATIVE MARKER: CIRCULATING TUMOR DNAstage II colon cancer, after tumour resectionEUCTR2019-000935-15-FRCentre Hospitalier Universitaire (CHU) de Dijon1,980
招募中
不适用
Quantification of Circulating tumor DNA to assess treatment response in metastatic prostate cancer patientsmetastatic prostate cancerNL-OMON24467Erasmus Medical Center95
招募中
1 期
Dynamics of circulating tumor DNA (ctDNA) and extracellular vesicle (EVs) for diagnosis, therapy monitoring, and prognosis assessment in solid visceral tumors.C15C18C19C22C23C24C25C26C49C16C48.2Malignant neoplasm of oesophagusMalignant neoplasm of colonMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of liver and intrahepatic bile ductsMalignant neoplasm of gallbladderMalignant neoplasm of other and unspecified parts of biliary tractMalignant neoplasm of pancreasMalignant neoplasm of other and ill-defined digestive organsMalignant neoplasm of other connective and soft tissueMalignant neoplasm of stomachPeritoneum, unspecifiedDRKS00028154niversitätklinikum Münster (UKM) Klinik füt Allgemein-, Viszeral- und Transplantationschirurgie. Direktor: Univ.-Prof. Dr. med. A. Pascher, MBA, FEBS100
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with thyroid cancerC73Malignant neoplasm of thyroid glandDRKS00022441niversitätsklinikum Freiburg75